Longeveron Announces First Quarter 2024 Financial Results and Provides Business Update
LGVN Stock | USD 1.52 0.01 0.65% |
About 61% of Longeveron LLC's investor base is looking to short. The analysis of the overall investor sentiment regarding Longeveron LLC suggests that many traders are alarmed. Longeveron LLC's investing sentiment overview a quick insight into current market opportunities from investing in Longeveron LLC. Many technical investors use Longeveron LLC stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Longeveron |
Phase 2b clinical trial evaluating Lomecel-BTM in rare pediatric disease HLHS on track for completing enrollment by end of 2024Data from Phase 2a clinical trial evaluating Lomecel-BTM in Alzheimers Disease selected for Featured Research Oral Presentation at 2024 Alzheimers Association International ConferenceCompleted two financings in April raising gross proceeds of 11.4 million to fund continued clinical developmentFocused expenditure management reduced first quarter Total Operating Expense
Read at finance.yahoo.com
![]() |
Longeveron LLC Fundamental Analysis
We analyze Longeveron LLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Longeveron LLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Longeveron LLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Longeveron LLC is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Longeveron LLC Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Longeveron LLC stock to make a market-neutral strategy. Peer analysis of Longeveron LLC could also be used in its relative valuation, which is a method of valuing Longeveron LLC by comparing valuation metrics with similar companies.
Peers
Longeveron LLC Related Equities
INDP | Indaptus Therapeutics | 6.33 | ||||
ERAS | Erasca | 6.20 | ||||
CCCC | C4 Therapeutics | 4.23 | ||||
LRMR | Larimar Therapeutics | 3.77 | ||||
KRON | Kronos Bio | 2.08 | ||||
NTRB | Nutriband | 0.83 | ||||
KROS | Keros Therapeutics | 0.64 | ||||
EWTX | Edgewise Therapeutics | 0.83 | ||||
RNXT | RenovoRx | 0.99 | ||||
ABVC | ABVC Biopharma | 1.23 | ||||
REVB | Revelation Biosciences | 1.67 | ||||
BOLT | Bolt Biotherapeutics | 2.08 | ||||
FBRX | Forte Biosciences | 2.15 | ||||
VRAX | Virax Biolabs | 2.34 | ||||
KPRX | Kiora Pharmaceuticals | 2.99 | ||||
KZR | Kezar Life | 3.06 | ||||
SRZN | Surrozen | 3.12 | ||||
GBIO | Generation Bio | 3.57 | ||||
KTTA | Pasithea Therapeutics | 4.92 | ||||
QNRX | Quoin Pharmaceuticals | 13.89 |
Check out Longeveron LLC Hype Analysis, Longeveron LLC Correlation and Longeveron LLC Performance. To learn how to invest in Longeveron Stock, please use our How to Invest in Longeveron LLC guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Longeveron LLC. If investors know Longeveron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Longeveron LLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Longeveron LLC is measured differently than its book value, which is the value of Longeveron that is recorded on the company's balance sheet. Investors also form their own opinion of Longeveron LLC's value that differs from its market value or its book value, called intrinsic value, which is Longeveron LLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Longeveron LLC's market value can be influenced by many factors that don't directly affect Longeveron LLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Longeveron LLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Longeveron LLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Longeveron LLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.